MegaRobo Raises $200 Million for Core Technology and Lab Infrastructure
The funding brings the China-based robotics company’s total raised to $600 million. Investors in the round included Oman Investment Authority, Asia Investment Capital, Granite Asia, Sinovation Ventures and CMB Interna…

MegaRobo announced $200 million in new funding on Nov. 19 to invest in its core technology and expand automated life sciences infrastructure, adding capital to a company building robotic systems for physical experiments.
The China-based company has raised $600 million across multiple funding rounds. That total includes nearly $300 million from a Series C round in 2022. Investors in the latest round included Oman Investment Authority, Asia Investment Capital, Granite Asia, Sinovation Ventures and CMB International.
Founded in 2016, MegaRobo develops robotic systems that allow artificial intelligence software to run physical experiments, as well as precision measurement and inspection tools. Its Megalaxy Lab platform lets researchers and AI agents configure experiments, route them through automated laboratory systems, track their execution and receive structured, machine-readable results.
The company also makes laboratory instruments, including the CellVue T2000 automated cell-imaging system. MegaRobo is developing One Intelligence Stack as a technology foundation spanning instruments, machines, materials processes and real-world feedback.
MegaRobo is working with Tencent Cloud and Twist Bioscience on Poreva Open, a global AI protein-design challenge open to all models and technical approaches. Megalaxy Lab will provide wet-lab validation for more than 10,000 protein design sequences, allowing the designs to be tested against experimental data.
Founder and Chief Executive Daniel Huang said the next generation of AI will increasingly learn through experiments, production and continuous feedback in the physical world. He said that shift could help AI create new knowledge, materials, processes and products.